| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1084782249 |
| P356 | DOI | 10.1038/S41523-017-0017-7 |
| P932 | PMC publication ID | 5460113 |
| P698 | PubMed publication ID | 28649653 |
| P2093 | author name string | Erik Teugels | |
| Sylvia De Brakeleer | |||
| P2860 | cites work | Cancer genome landscapes | Q22242276 |
| Mutation and cancer: statistical study of retinoblastoma | Q24618185 | ||
| Genome-wide association study identifies novel breast cancer susceptibility loci | Q24645441 | ||
| Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions | Q26261171 | ||
| Mutational signatures: the patterns of somatic mutations hidden in cancer genomes | Q26850125 | ||
| CHEK2*1100delC homozygosity is associated with a high breast cancer risk in women. | Q51392341 | ||
| Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2. | Q53392865 | ||
| The emerging landscape of breast cancer susceptibility | Q57272203 | ||
| Loss of nuclear BRCA1 protein staining in normal tissue cells derived from BRCA1 and BRCA2 mutation carriers | Q62490486 | ||
| The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families | Q62978228 | ||
| Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2 | Q64388717 | ||
| Polygenes, risk prediction, and targeted prevention of breast cancer | Q81523323 | ||
| Public health implications from COGS and potential for risk stratification and screening | Q86499074 | ||
| Mutations of the BRAF gene in human cancer | Q27860760 | ||
| A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 | Q28115843 | ||
| Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations | Q28215462 | ||
| Cancer-susceptibility genes. Gatekeepers and caretakers | Q28236512 | ||
| The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer | Q28256988 | ||
| Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes | Q28307762 | ||
| Signatures of mutational processes in human cancer | Q29547191 | ||
| COSMIC: exploring the world's knowledge of somatic mutations in human cancer | Q29615725 | ||
| Identification of the breast cancer susceptibility gene BRCA2 | Q29616290 | ||
| Landscape of somatic mutations in 560 breast cancer whole-genome sequences | Q34046731 | ||
| Epigenomic alterations define lethal CIMP-positive ependymomas of infancy | Q34240198 | ||
| BRCA1 haploinsufficiency for replication stress suppression in primary cells | Q34568339 | ||
| Nonsense-mediated decay in genetic disease: friend or foe? | Q34658988 | ||
| A general theory of carcinogenesis | Q34744320 | ||
| A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population | Q35089479 | ||
| Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells | Q35470405 | ||
| Origins and selection of p53 mutations in lung carcinogenesis | Q36010485 | ||
| Prediction of breast cancer risk based on profiling with common genetic variants | Q36583004 | ||
| Models of genetic susceptibility to breast cancer | Q36602581 | ||
| Clock-like mutational processes in human somatic cells | Q36666868 | ||
| Mutator phenotype may be required for multistage carcinogenesis | Q37732904 | ||
| In brief: BRCA1 and BRCA2. | Q38101887 | ||
| Mechanisms underlying mutational signatures in human cancers | Q38225013 | ||
| Molecular targeted therapy in the treatment of advanced stage non-small cell lung cancer (NSCLC). | Q38358410 | ||
| Differential DNA mismatch repair underlies mutation rate variation across the human genome | Q38906828 | ||
| Tissue-specific mutation accumulation in human adult stem cells during life | Q40555695 | ||
| Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis | Q40694250 | ||
| Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer | Q48084125 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 13 | |
| P577 | publication date | 2017-04-17 | |
| P1433 | published in | NPJ Breast Cancer | Q27727120 |
| P1476 | title | An alternative model for (breast) cancer predisposition | |
| P478 | volume | 3 |
| Q64075131 | Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families | cites work | P2860 |
Search more.